Abstract
Vesicular stomatitis virus and encephalomyocarditis virus do not multiply in the majority of peritoneal macrophages freshly explanted from 4- to 8-week-old male or female mice. However, when peritoneal macrophages were cultivated in vitro for 3 to 5 days, these cells became permissive for both viruses. The loss of antiviral state in "aged" macrophages paralleled a significant decrease in the intracellular levels of (2'-5')oligo-adenylate synthetase activity. Although biologically active interferon was not detected in the nutrient medium of macrophage cultures, freshly harvested peritoneal cells could confer an antiviral state on monolayer cultures of mouse cells (aged macrophages, embryonic fibroblasts, and L cells) but not on heterologous chicken embryo, rabbit kidney, or human cells infected with vesicular stomatitis virus or encephalomyocarditis virus. The conferred antiviral state required at least 7 h to develop in target cells and was totally inhibited by the presence of antibody to mouse interferon alpha/beta but not to interferon gamma in the cocultures. Heterologous guinea pig and rabbit peritoneal cells could not transfer an antiviral state to target mouse cells. Donor peritoneal cells from mice preinjected with antibody to interferon alpha/beta could not transfer an antiviral state to target mouse cells. This ensemble of results indicating that freshly harvested peritoneal cells transfer interferon (which is responsible for inducing an antiviral state in susceptible mouse target cells) adds further experimental evidence that interferon is spontaneously expressed in normal mice and plays an important role in maintaining some host cells in an antiviral state.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Belardelli F., Vignaux F., Proietti E., Gresser I. Injection of mice with antibody to interferon renders peritoneal macrophages permissive for vesicular stomatitis virus and encephalomyocarditis virus. Proc Natl Acad Sci U S A. 1984 Jan;81(2):602–606. doi: 10.1073/pnas.81.2.602. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Benedetto A., Rossi G. B., Amici C., Belardelli F., Cioè L., Carruba G., Carrasco L. Inhibition of animal virus production by means of translation inhibitors unable to penetrate normal cells. Virology. 1980 Oct 15;106(1):123–132. doi: 10.1016/0042-6822(80)90227-5. [DOI] [PubMed] [Google Scholar]
- Blalock J. E., Baron S. Interferon-induced transfer of viral resistance between animal cells. Nature. 1977 Sep 29;269(5627):422–425. doi: 10.1038/269422a0. [DOI] [PubMed] [Google Scholar]
- Blalock J. E., Baron S. Mechanisms of interferon induced transfer of viral resistance between animal cells. J Gen Virol. 1979 Feb;42(2):363–372. doi: 10.1099/0022-1317-42-2-363. [DOI] [PubMed] [Google Scholar]
- Blalock J. E., Stanton G. J. Efficient transfer of interferon-induced virus resistance between human cells. J Gen Virol. 1978 Nov;41(2):325–331. doi: 10.1099/0022-1317-41-2-325. [DOI] [PubMed] [Google Scholar]
- Bocci V., Muscettola M., Paulesu L., Grasso G. The physiological interferon response. II. Interferon is present in lymph but not in plasma of healthy rabbits. J Gen Virol. 1984 Jan;65(Pt 1):101–108. doi: 10.1099/0022-1317-65-1-101. [DOI] [PubMed] [Google Scholar]
- Bocci V. Production and role of interferon in physiological conditions. Biol Rev Camb Philos Soc. 1981 Feb;56(1):49–85. doi: 10.1111/j.1469-185x.1981.tb00343.x. [DOI] [PubMed] [Google Scholar]
- Dianzani F., Baron S. Unexpectedly rapid action of human interferon in physiological conditions. Nature. 1975 Oct 23;257(5528):682–684. doi: 10.1038/257682a0. [DOI] [PubMed] [Google Scholar]
- Glasgow L. A. Transfer of interferon-producing macrophages: new approach to viral chemotherapy. Science. 1970 Nov 20;170(3960):854–856. doi: 10.1126/science.170.3960.854. [DOI] [PubMed] [Google Scholar]
- Gresser I., Belardelli F., Maury C., Maunoury M. T., Tovey M. G. Injection of mice with antibody to interferon enhances the growth of transplantable murine tumors. J Exp Med. 1983 Dec 1;158(6):2095–2107. doi: 10.1084/jem.158.6.2095. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gresser I., Bourali C., Thomas M. T., Falcoff E. Effect of repeated inoculation of interferon preparations on infection of mice with encephalomyocarditis virus. Proc Soc Exp Biol Med. 1968 Feb;127(2):491–496. doi: 10.3181/00379727-127-32723. [DOI] [PubMed] [Google Scholar]
- Gresser I., Tovey M. G., Bandu M. E., Maury C., Brouty-Boyé D. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. I. Rapid evolution of encephalomyocarditis virus infection. J Exp Med. 1976 Nov 2;144(5):1305–1315. doi: 10.1084/jem.144.5.1305. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gresser I., Vignaux F., Belardelli F., Tovey M. G., Maunoury M. T. Injection of mice with antibody to mouse interferon alpha/beta decreases the level of 2'-5' oligoadenylate synthetase in peritoneal macrophages. J Virol. 1985 Jan;53(1):221–227. doi: 10.1128/jvi.53.1.221-227.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ito Y., Aoki H., Kimura Y., Takano M., Shimokata K., Maeno K. Natural interferon-producing cells in mice. Infect Immun. 1981 Feb;31(2):519–523. doi: 10.1128/iai.31.2.519-523.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lebon P., Girard S., Thépot F., Chany C. Présence constante d'interféron de type alpha dans les liquides amniotiques humains. C R Seances Acad Sci III. 1981 Jul 6;293(1):69–71. [PubMed] [Google Scholar]
- Reid L. M., Minato N., Gresser I., Holland J., Kadish A., Bloom B. R. Influence of anti-mouse interferon serum on the growth and metastasis of tumor cells persistently infected with virus and of human prostatic tumors in athymic nude mice. Proc Natl Acad Sci U S A. 1981 Feb;78(2):1171–1175. doi: 10.1073/pnas.78.2.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sen G. C. Mechanism of interferon action: progress toward its understanding. Prog Nucleic Acid Res Mol Biol. 1982;27:105–156. doi: 10.1016/s0079-6603(08)60599-1. [DOI] [PubMed] [Google Scholar]
- Spitalny G. L., Havell E. A. Monoclonal antibody to murine gamma interferon inhibits lymphokine-induced antiviral and macrophage tumoricidal activities. J Exp Med. 1984 May 1;159(5):1560–1565. doi: 10.1084/jem.159.5.1560. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tovey M. G., Begon-Lours J., Gresser I. A method for the large scale production of potent interferon preparations. Proc Soc Exp Biol Med. 1974 Jul;146(3):809–815. doi: 10.3181/00379727-146-38196. [DOI] [PubMed] [Google Scholar]
- Trapman J. Distinct antigenic character of two components of poly(I).poly(C)-induced mouse L cell interferon. FEBS Lett. 1980 Jan 1;109(1):137–140. doi: 10.1016/0014-5793(80)81328-7. [DOI] [PubMed] [Google Scholar]
- Vogel S. N., Fertsch D. Endogenous interferon production by endotoxin-responsive macrophages provides an autostimulatory differentiation signal. Infect Immun. 1984 Aug;45(2):417–423. doi: 10.1128/iai.45.2.417-423.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]